Literature DB >> 28626194

Spontaneous Improvement of Interstitial Pneumonia with Autoimmune Features.

Keishi Oda1, Takako Kawaguchi1, Minoru Satoh2, Kazuhiro Yatera1.   

Abstract

Entities:  

Keywords:  anti-EJ antibody; interstitial pneumonia with autoimmune features

Year:  2017        PMID: 28626194      PMCID: PMC5505924          DOI: 10.2169/internalmedicine.56.8082

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 66-year-old man, diagnosed with interstitial pneumonia based on high-resolution computed tomography (HRCT) findings (Picture 1) presented to our hospital due to a persistent dry cough with desaturation. Pulmonary function tests showed a reduced forced vital capacity of 1.90 L (51% predicted) and a decreased diffusing capacity for carbon monoxide (65% predicted). A surgical lung biopsy revealed nonspecific interstitial pneumonia (Picture 2A). Anti-EJ (glycyl tRNA synthetase) antibodies were positive on immunoprecipitation using 35S-methionine-labeled K562 cell extract (Picture 2B). He did not meet the criteria for polymyositis and dermatomyositis and was diagnosed with interstitial pneumonia with autoimmune features (IPAF) (1). He declined corticosteroids and/or immunosuppressant therapy. A year later, spontaneous improvement of the features, including the desaturation, HRCT findings (Picture 3) and pulmonary function tests was noted. IPAF can show various clinical courses (2); we herein report the first known case of IPAF that spontaneously improved without any treatment.
Picture 1.
Picture 2.
Picture 3.
The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.

Authors:  Aryeh Fischer; Katerina M Antoniou; Kevin K Brown; Jacques Cadranel; Tamera J Corte; Roland M du Bois; Joyce S Lee; Kevin O Leslie; David A Lynch; Eric L Matteson; Marta Mosca; Imre Noth; Luca Richeldi; Mary E Strek; Jeffrey J Swigris; Athol U Wells; Sterling G West; Harold R Collard; Vincent Cottin
Journal:  Eur Respir J       Date:  2015-07-09       Impact factor: 16.671

2.  Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.

Authors:  Hazuki Takato; Yuko Waseda; Satoshi Watanabe; Kanako Inuzuka; Nobuyuki Katayama; Yukari Ichikawa; Masahide Yasui; Masaki Fujimura
Journal:  Respir Med       Date:  2012-11-06       Impact factor: 3.415

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.